Рубрика
Blog
-
2023
-
Viatris, Cipla and Aurobindo sign up to make generics of GSK’s long-acting HIV PrEP drug
-
EU Approves Amicus Therapeutics Pombiliti for Late-Onset Pompe Disease
-
AstraZeneca, Amgen’s asthma launch Tezspire picks up backing from England’s NICE
-
Cyclerion’s Mitochondrial Diseases Candidate Receives Orphan Drug Designation: Advancing Treatment Options for Patients
-
Glenmark Pharmaceuticals’ Generic of Leo Pharma’s Enstilar Approved
-
Incyte Gets CRL for Jakafi Extended-Release Tablets
-
NICE Recommends Upstaza for Rare Genetic Disorder
-
FDA Approves First-Ever Treatment for Activated Phosphoinositide 3-Kinase Delta Syndrome
-
AstraZeneca and Ionis build case for amyloidosis drug eplontersen
-
AbbVie Hits Snag for Parkinson’s Disease Candidate